P3 Health Partners Inc. Class A Common Stock (NAS: PIII) Stock Analysis & Fundamentals

PIIIP3 Health Partners Inc. Class A Common Stock

NAS · US · Healthcare · Medical Care Facilities · p3hp.org

10.29USD+0.19%Mkt Cap: 2.05B $P/E: —2d ago

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded …

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA Inhaber-Aktien o.N.

$28.29BUSDP/E 16.7

THC

Tenet Healthcare Corporation

$21.62BUSDP/E 10.4

FME

Fresenius Medical Care AG & Co. KGaA

$11.94BUSDP/E 12.3

EHC

Encompass Health Corporation

The Ensign Group, Inc.

$10.64BUSDP/E 28.6

UHS

Universal Health Services, Inc. Class B

LifeStance Health Group Inc. Common Stock

$4.90BUSDP/E 98.7

CON

Concentra Group Holdings Parent Inc. Common Stock

National HealthCare Corporation

$3.67BUSDP/E 26.3

OPCH

Option Care Health, Inc.

$3.50BUSDP/E 17.7

BKD

Brookdale Senior Living Inc.

$2.89BUSD

AVAH

Aveanna Healthcare Holdings Inc.

Acadia Healthcare Company, Inc.

$2.55BUSD

GRDN

Guardian Pharmacy Services Inc. Class A Common Stock

$2.41BUSDP/E 36.5

Key Statistics

Company

Market Cap2.05B $

Enterprise Value379.76M $

Revenue (TTM)1.50B $

Gross Profit70.59M $

Net Income (TTM)-147.95M $

Revenue/Share455.40 USD

Last Price10.29 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees320

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-49.24

PEG—

EV/EBITDA-5.89

EV/Revenue0.25

P/S1.38

P/B-0.44

EPS (TTM)-32.95

EPS (Forward)-0.21

52W Range

1.52058% of range16.54

52W High16.54 USD

52W Low1.520 USD

Profitability

Gross Margin4.70%

Oper. Margin10.67%

EBITDA Margin-4.29%

Profit Margin-10.14%

ROE95.31%

ROA-22.53%

Growth

Revenue Growth8.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-91.24M $

CapEx (TTM)—

FCF Margin-8.27%

FCF Yield-6.05%

Net Debt109.42M $

Net Debt/EBITDA-1.70

Balance Sheet

Debt/Equity-1.84

Current Ratio0.46

Quick Ratio0.43

Book Value/Sh-23.5930 USD

Cash/Share5.438 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:50

Split DateApr 14, 2025

Analyst Consensus

Rating2.0 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)18.00 USD

Upside (mean)+74.9%

Target Range13.00 USD – 23.00 USD

$13.00+74.9% to mean$23.00

# Analysts2

Ownership

Shares Out.3.91M

Float1.92M

Insiders48.38%

Institutions8.24%

Short Interest

Short Ratio1.4d

Short % Float1.42%

Short % Out.1.08%

Shares Short35.98K

Short (prev mo.)48.84K

Technical

SMA 5010.88 (-5.4%)

SMA 2006.166 (+66.9%)

Beta1.64

S&P 52W Chg18.16%

Avg Vol (30d)45.31K

Avg Vol (10d)113.58K

Technical Indicators

RSI (14)46.0

MACD0.1117

MACD Signal0.1565

MACD Hist.-0.0448

BB Upper12.42 USD

BB Middle10.64 USD

BB Lower8.857 USD

BB Width33.48%

ATR (14)1.052 USD

Vol Ratio (20d)0.17x